Fully automatic aseptic liquid filling system - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fully automatic aseptic liquid filling system


The FPC50W is a flexible aseptic filling system with integrated full or partial stoppering and crimp capping of vials. The system can deliver fill volumes ranging from 0.1ml to 100ml and a filling accuracy of ± 0.5% which is check-weighed throughout the filling batch, with adjustments made automatically if required.

The FPC50W is ideally suited to applications involving small batches such as contract fillers and research and development trials where cross contamination must be avoided. For example, the use of Flexicon's asepticsu sterile, disposable tubing, filling needles and fluid bags, ensures minimal human contact with the filling operation. In addition, the entire single-use fluid path is contained, making cleaning and validation extremely simple.

As well as check-weighing 100% of the vials filled, the FPC50W also permits fast change-over between batches of liquids to be filled. This helps to eliminate time consuming and costly logistic procedures related to having dedicated pumps in stock.

Peristaltic pumps are ideally suited to filling applications: they provide superior flow rate stability and metering accuracy; facilitate aseptic and sterile processes; have extensive chemical compatibility; and are inherently hygienic and safe to run.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
Improves the quality and number of innovative drugs available to patients.
Restricts innovation and the development of new drugs.
Has no impact on drug development.
Do not know.
Improves the quality and number of innovative drugs available to patients.
29%
Restricts innovation and the development of new drugs.
54%
Has no impact on drug development.
4%
Do not know.
13%
Eric Langer Outsourcing Outlook Eric LangerOutsourcing No Longer Just for Cost-Cutting
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerSeeking Alternative Catalyst Solutions
Jill Wechsler Regulatory Watch Jill Wechsler Global Expansion Shapes Drug Oversight
Chris Burgess Statistical Solutions Chris BurgessIs a Sample Size of n=6 a Magic Number?
Sean Milmo European Regulatory WatchSean MilmoRegulating the Environmental Impact of Pharmaceuticals
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Report: Pfizer Makes $101 Billion Offer to AstraZeneca

Click here